Melanoma trials in Greece

1 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

  Where

  Athens

  Age

  18 years and over

  People

  50 worldwide

  Run by

  Replimune, Inc.

  See details and how to joinNCT06887348 · EU 2025-521621-33-00